Full-Time

Supplier Quality Engineer

Updated on 7/21/2026

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Noida, Uttar Pradesh, India

Hybrid

Hybrid role; in-office presence required in Gurugram, Haryana.

Category
QA & Testing (1)
Required Skills
Sharepoint
Excel/Numbers/Sheets

Get referred to Stryker

Find people who can refer or advise you

Requirements
  • Bachelor’s degree (Supply Chain Management, Engineering, Quality or equivalent)
  • 2+ years in handling Quality management systems, Supplier audits, agreements etc.
  • 2+ years in Supply Management or Sourcing or other relevant functions
  • Working knowledge of ISO 13485
  • Ability to effectively communicate and present information to suppliers, team members, team leaders, and top management
  • Ability to build relationships across multiple functions and levels both internally and externally
  • Knowledge of continuous improvement methodologies & cost reduction methodologies
  • Knowledge of supplier metrics & measurement methodologies and supporting systems
  • PC Literate (Track-wise, Excel, SharePoint). Basic knowledge of project Management tools is desirable
  • Strong analytical skills
  • Travel Percentage: 10%
Responsibilities
  • Lead quality issues with suppliers with Internal business partners; Lead effective supplier containment and corrections/corrective actions.
  • Act as point of contact for Internal/ External Customer groups on key compliance issues related to assigned suppliers.
  • Participate in External Audits and Internal Audits as needed. Ensure Regulatory compliance in area of responsibility to GMP of all medical device’s regulatory agencies (i.e. FDA, IMB, Notified bodies, etc.)
  • Management of SQA.
  • Responsible for accuracy and integrity of supplier data that ensures compliance with documented procedures & processes.
  • Ownership and reporting on all quality issues associated with the assigned suppliers. Ensure all assigned supplier related material quality issues are effectively communicated to key stakeholders.
  • Maintain structured communication channels with strategic sourcing, identifying responsibility by commodity / supplier.
  • Liaising with the Manufacturing and Quality groups, in assessing and addressing material quality issues with assigned suppliers.
  • Maintenance of the Approved Supplier List (ASL) in conjunction with the Mergers and Acquisitions, Global Sourcing, regulatory, Supplier controls and Audit functions.
  • Deliver continuous improvement activities focusing on supplier quality.
  • Participate as required in SCRB in conjunction with key stakeholders & support assessment of supplier changes.
  • Participate in supplier audit program – planning, execution and closure.
  • Participate in supplier reviews for assigned suppliers as required.
  • Participate in cross functional projects both locally & globally as required.
  • Partner with SQM functions and Strategic Sourcing on the developments and approval quality assurance agreements with suppliers.
Desired Qualifications
  • Basic knowledge of project Management tools is desirable

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Vascular division jumped 27.5% following Inari acquisition, boosting organic growth outlook.
  • Trident II Acetabular System launched in India, targeting rising hip replacement demand from aging populations.
  • Free cash flow rose 227% to $415 million, strengthening capital efficiency and investor returns.

What critics are saying

  • March 11, 2026 cyberattack by Handala disrupted global manufacturing, causing high-impact Q1 earnings miss.
  • BofA cut price target to $380 on medtech slowdown, reducing 2027 earnings estimates due to soft utilization.
  • Intuitive Surgical's 39x earnings vs Stryker's 22x risks valuation erosion in joint-replacement markets.

What makes Stryker unique

  • Pangea Plating System launched in Europe on May 26, 2026, addressing diverse fractures without plate bending.
  • Mako-driven orthopaedics franchise grows with integrated robotics for total joint and trauma procedures.
  • TPX HD power tool delivers 296% more torque for demanding orthopaedic revision surgeries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.